Berdel WE - Search Results

1

Subcutaneous zygomycosis in neutropenia.

Mikesch JH, Rudat A, Zühlsdorf M, Berdel WE, Mesters R, Conrad B, Becker K, Fegeler W, Anthoni C. Mikesch JH, et al. Among authors: berdel we. J Clin Oncol. 2007 Oct 20;25(30):4844-5. doi: 10.1200/JCO.2007.13.4320. J Clin Oncol. 2007. PMID: 17947734 No abstract available.

2

Tissue inhibitor of metalloproteinases 1 is an autocrine and paracrine survival factor, with additional immune-regulatory functions, expressed by Hodgkin/Reed-Sternberg cells.

Oelmann E, Herbst H, Zühlsdorf M, Albrecht O, Nolte A, Schmitmann C, Manzke O, Diehl V, Stein H, Berdel WE. Oelmann E, et al. Among authors: berdel we. Blood. 2002 Jan 1;99(1):258-67. doi: 10.1182/blood.v99.1.258. Blood. 2002. PMID: 11756180 Free article.

3

Efficacy and safety of thalidomide in patients with acute myeloid leukemia.

Steins MB, Padró T, Bieker R, Ruiz S, Kropff M, Kienast J, Kessler T, Buechner T, Berdel WE, Mesters RM. Steins MB, et al. Among authors: berdel we. Blood. 2002 Feb 1;99(3):834-9. doi: 10.1182/blood.v99.3.834. Blood. 2002. PMID: 11806984 Free article. Clinical Trial.

4

The catalytic domain of endogenous urokinase-type plasminogen activator is required for the mitogenic activity of platelet-derived and basic fibroblast growth factors in human vascular smooth muscle cells.

Padró T, Mesters RM, Dankbar B, Hintelmann H, Bieker R, Kiehl M, Berdel WE, Kienast J. Padró T, et al. Among authors: berdel we. J Cell Sci. 2002 May 1;115(Pt 9):1961-71. doi: 10.1242/jcs.115.9.1961. J Cell Sci. 2002. PMID: 11956327

5

Interleukin 8 and Flt3 ligand as markers of advanced disease in primary gastrointestinal non-Hodgkin's lymphoma.

Retzlaff S, Padró T, Koch P, Oelmann E, Lügering N, Mesters RM, Berdel WE. Retzlaff S, et al. Among authors: berdel we. Oncol Rep. 2002 May-Jun;9(3):525-7. Oncol Rep. 2002. PMID: 11956621

6

Carboplatin/etoposide induces remission of metastasised malignant peripheral nerve tumours (malignant schwannoma) refractory to first-line therapy.

Steins MB, Serve H, Zühlsdorf M, Senninger N, Semik M, Berdel WE. Steins MB, et al. Among authors: berdel we. Oncol Rep. 2002 May-Jun;9(3):627-30. Oncol Rep. 2002. PMID: 11956640

7

Paracrine interactions of basic fibroblast growth factor and interleukin-6 in multiple myeloma.

Bisping G, Leo R, Wenning D, Dankbar B, Padró T, Kropff M, Scheffold C, Kröger M, Mesters RM, Berdel WE, Kienast J. Bisping G, et al. Among authors: berdel we. Blood. 2003 Apr 1;101(7):2775-83. doi: 10.1182/blood-2002-09-2907. Epub 2002 Nov 27. Blood. 2003. PMID: 12517814 Free article.

8

Osteosarcoma of the pelvis: experience of the Cooperative Osteosarcoma Study Group.

Ozaki T, Flege S, Kevric M, Lindner N, Maas R, Delling G, Schwarz R, von Hochstetter AR, Salzer-Kuntschik M, Berdel WE, Jürgens H, Exner GU, Reichardt P, Mayer-Steinacker R, Ewerbeck V, Kotz R, Winkelmann W, Bielack SS. Ozaki T, et al. Among authors: berdel we. J Clin Oncol. 2003 Jan 15;21(2):334-41. doi: 10.1200/JCO.2003.01.142. J Clin Oncol. 2003. PMID: 12525527

9

Phase I study of liposomal daunorubicin in relapsed and refractory acute myeloid leukemia.

Bieker R, Lerchenmüller C, Wehmeyer J, Serve HL, Mesters RM, Büchner T, Berdel WE. Bieker R, et al. Among authors: berdel we. Oncol Rep. 2003 Jul-Aug;10(4):915-20. Oncol Rep. 2003. PMID: 12792745 Clinical Trial.

10

Synergistic growth inhibitory effects of interferon-alpha and lovastatin on bcr-abl positive leukemic cells.

Müller-Tidow C, Kiehl M, Sindermann JR, Probst M, Banger N, Zühlsdorf M, Chou TC, Berdel WE, Serve H, Koch OM. Müller-Tidow C, et al. Among authors: berdel we. Int J Oncol. 2003 Jul;23(1):151-8. Int J Oncol. 2003. PMID: 12792788

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

629 results

Search Page

Filters